Zhili Chang

Title: Zhili Chang - Innovator in Sequencing Data Analysis

Introduction

Zhili Chang is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the area of sequencing data analysis. His innovative work focuses on improving the detection of microsatellite instability, which is crucial for various medical applications.

Latest Patents

Zhili Chang holds a patent for a "Sequencing data analysis method, device and computer-readable medium for microsatellite instability." This invention utilizes next-generation sequencing (NGS) results to determine the presence of microsatellite instability. The method enhances detection sensitivity without compromising specificity. It allows for the rapid and automatic evaluation of the stability status of each MSI locus with high throughput, sensitivity, and specificity. By integrating the statuses of all MSI loci in each sample, the samples can be comprehensively classified as MSS, MSI-L, or MSI-H.

Career Highlights

Zhili Chang is associated with Nanjing Shihe Gene Biotechnology Co., Ltd., where he applies his expertise in sequencing technologies. His work has been instrumental in advancing the capabilities of genetic analysis and diagnostics.

Collaborations

Zhili Chang collaborates with notable colleagues, including Yang Shao and Xue Wu. Their combined efforts contribute to the ongoing research and development in the field of biotechnology.

Conclusion

Zhili Chang's innovative contributions to sequencing data analysis have the potential to significantly impact the field of genetics and diagnostics. His work exemplifies the importance of advancements in biotechnology for improving healthcare outcomes.